Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graft vs. Host Disease (GvHD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05500950
What this trial is testing

Color Doppler Ultrasound in Lacrimal Sac Space-occupying Lesions

Who this might be right for
Dacryocystitis; ChronicLacrimal Sac Space-occupying LesionsColor Doppler Ultrasound+1 more
Wenzhou Medical University 21
Early research (Phase 1)UnknownNCT03836690
What this trial is testing

Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

Who this might be right for
LymphomaLeukemiaMyeloma+4 more
University College, London 18
Not applicableNot Yet RecruitingNCT07539220
What this trial is testing

Establishment of Biomarker Panel For Forecasting Chronic Graft-Versus-Host Disease (cGVHD) After Allo-HSCT

Who this might be right for
Chronic Graft-Versus-Host Disease
Institute of Hematology & Blood Diseases Hospital, China 1,500
Testing effectiveness (Phase 2)Study completedNCT01334060
What this trial is testing

WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular Electroporation

Who this might be right for
Leukaemia (Acute)Leukaemia (Chronic)Leukaemia (Acute Myeloid)+2 more
University Hospital Southampton NHS Foundation Trust 23
Testing effectiveness (Phase 2)Ended earlyNCT02702518
What this trial is testing

RhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease

Who this might be right for
Ocular Graft vs Host DiseaseDry Eye
University of Illinois at Chicago 58
Large-scale testing (Phase 3)Ended earlyNCT00662220
What this trial is testing

High-dose Ribavirin in Treatment of Chronic Hepatitis C Genotype 1 or 4

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 110
Testing effectiveness (Phase 2)UnknownNCT04778618
What this trial is testing

Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 63
Not applicableStudy completedNCT03727113
What this trial is testing

Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors

Who this might be right for
Hematopoietic Stem Cell TransplantationGraft Versus Host Disease
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 211
Testing effectiveness (Phase 2)Study completedNCT00391820
What this trial is testing

Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)

Who this might be right for
Chronic Constipation
Alfasigma S.p.A. 360
Early research (Phase 1)Study completedNCT05673876
What this trial is testing

Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Acute Graft-versus-host Disease
Genentech, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00639717
What this trial is testing

Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant

Who this might be right for
Graft Versus Host Disease
University of Michigan Rogel Cancer Center 48
Testing effectiveness (Phase 2)Study completedNCT01487577
What this trial is testing

Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention

Who this might be right for
Allogeneic Blood and Marrow Transplantation (BMT)Graft Versus Host Disease
University of Pittsburgh 19
Not applicableActive Not RecruitingNCT05186857
What this trial is testing

Metabolome and Microbiome Impact on Acute GVHD in Recipients of Hematopoietic Transplant

Who this might be right for
Graft-versus-host Disease
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 88
Not applicableActive Not RecruitingNCT07504094
What this trial is testing

Active Coping: Interdisciplinary Program for Chronic Pain, Physiotherapy Unit (Spain)

Who this might be right for
Chronic Back PainChronic PainBack Pain+3 more
Universidad de Zaragoza 20
Not applicableStudy completedNCT00270712
What this trial is testing

Factors That Affect Long-Term Kidney Transplant Function

Who this might be right for
Kidney Transplant
University of Minnesota 3,175
Testing effectiveness (Phase 2)WithdrawnNCT04204122
What this trial is testing

Vigamox Treatment for Ocular Graft-Versus-Host Disease

Who this might be right for
Ocular Graft-versus-host Disease
Washington University School of Medicine
Large-scale testing (Phase 3)Looking for participantsNCT07366801
What this trial is testing

Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia, RelapsedAcute Lymphoblastic Leukemia, High RiskAcute Myeloid Leukemia, High Risk+1 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Very early researchUnknownNCT00378677
What this trial is testing

Dry Powder Inhalation of Cyclosporine A in Lung Transplant Patients With Bronchiolitis Obliterans Syndrome

Who this might be right for
Lung TransplantationBronchiolitis Obliterans
University Medical Center Groningen 7
Not applicableUnknownNCT06394895
What this trial is testing

Donor Neutrophil Subsets to Predict the Risk of aGVHD

Who this might be right for
Acute Graft-versus-Host Disease
Nanfang Hospital, Southern Medical University 260
Testing effectiveness (Phase 2)Study completedNCT03082677
What this trial is testing

Study of Ixazomib to Prevent Recurrent or Late Acute and Chronic Graft-versus-Host Disease 1-year After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies

Who this might be right for
Myeloid Hematologic MalignancyLymphoid Hematologic Malignancy
Memorial Sloan Kettering Cancer Center 20
Next Page
64